Development of Multifunctional Materials (MFM): Bioabsorbable Drug-Releasing Hard Tissue Fixation Screws

Article Preview

Abstract:

To develop a successful bone fixation device that can also release therapeutic agents such as antibiotics one has to consider mechanical, drug release, and biocompatibility properties. We have used bioabsorbable polymers (PLGA 80/20 or PLDLA 70/30) as the matrix and ciprofloxacin (CF) as antibiotic to develop such an implant. Initial shear strengths of the studied ciprofloxacinreleasing screws were 152 MPa (P/L/DL)LA) and 172 MPa (PLGA). Studied screws retained their mechanical properties for least 12 weeks (P(L/DL)LA) and 9 weeks (PLGA) in vitro at the level that ensures their fixation properties. Pull-out tests indicated that the early version of screws have lower values as compared to controls. CF was found to be released after 44 weeks (P/L/DL)LA) and 23 weeks (PLGA) in vitro. It remained in the range of 0.06 – 8.7 µg/ml/day (for P(L/DL)LA) and 0.6 - 11.6 µg/ml/day (for PLGA) after the jump start. Release CF was demonstrated to significantly inhibit S. epidermides growth, attachment and biofilm formation different than controls. Histology showed no difference from plain polymer screws, except for increased giant cells at the implantation site. Accordingly, SR-P(L/DL)LA and SR-PLGA MF implants were considered appropriate to proceed to pilot clinical application.

You might also be interested in these eBooks

Info:

Periodical:

Materials Science Forum (Volumes 492-493)

Pages:

195-200

Citation:

Online since:

August 2005

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2005 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] H.W. Bucholz and E. Engelbrecht: Chirug. Vol. 41 (1970), p.511.

Google Scholar

[2] N. Ashammakhi, R. Suuronen, J. Tiainen, P. Törmälä and T. Waris: J. Craniofac. Surg. Vol. 14 (2003), p.247.

Google Scholar

[3] R. Suuronen, R. Kontio, N. Ashammakhi, C. Lindqvist C and P. Laine: Biomed. Mater. Eng. Vol. 14 (2004), p.517.

Google Scholar

[4] E. Waris, M. Ninkovic, C. Harpf, M. Ninkovic and N. Ashammakhi: J. Hand Surg. [Am]. Vol. 29 (2004), p.452.

DOI: 10.1016/j.jhsa.2004.01.013

Google Scholar

[5] K.L. Garvin, J.A. Miyano, D. Robinson D. Giger, J. Novak and S. Radio: J. Bone Joint Surg. Am. Vol. 76 (1994), p.1500.

Google Scholar

[6] J. Overbeck, S. Winckler, R. Meffert and P. Törmälä: H: J. Inv. Surg. Vol. 8 (1995), p.155.

Google Scholar

[7] J.H. Calhoun and J.T. Mader. Clin. Orthop. (1997), p.206.

Google Scholar

[8] P. Törmälä: Clin. Mater. Vol. 10 (1992), p.29.

Google Scholar

[9] L. Claes, K. Rehm and D. Hutmacher: Fourth World Biomaterials Congress 1992, April 24- 28, Berlin, 205.

Google Scholar

[10] Y.H. An, S.K. Woolf and R.J. Friedman: Biomaterials Vol. 21 (2000), p.2635.

Google Scholar

[11] H.P. Lambert and F.W. O'Grady: Quinolones (Antibiotic and Chemotherapy, 1992).

Google Scholar

[12] R. Ansorg, K.D. Muller and J. Wiora: Chemotherapy Vol. 36 (1990), p.222.

Google Scholar

[13] R. Wise, J.M. Andrews and L.J. Edwards: Antimicrob. Agents Chemother Vol. 23 (1983), p.559.

Google Scholar